Literature DB >> 18583713

Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone.

Bernhard Friedrich Peter1, Darcy Lidington, Aki Harada, Hanno Jörn Bolz, Lukas Vogel, Scott Heximer, Sarah Spiegel, Ulrich Pohl, Steffen-Sebastian Bolz.   

Abstract

Sphingosine-1-phosphate (S1P), which mediates pleiotropic actions within the vascular system, is a prominent regulator of microvascular tone. By virtue of its S1P-degrading function, we hypothesized that S1P-phosphohydrolase 1 (SPP1) is an important regulator of tone in resistance arteries. Hamster gracilis muscle resistance arteries express mRNA encoding SPP1. Overexpression of SPP1 (via transfection of a SPP1(wt)) reduced resting tone, Ca2+ sensitivity, and myogenic vasoconstriction, whereas reduced SPP1 expression (antisense oligonucleotides) yielded the opposite effects. Expression of a phosphatase-dead mutant of SPP1 (SPP1(H208A)) had no effect on any parameter tested, suggesting that catalytic activity of SPP1 is critical. The enhanced myogenic tone that follows overexpression of S1P-generating enzyme sphingosine kinase 1 (Sk1(wt)) was functionally antagonized by coexpression with SPP1(wt) but not SPP1(H208A). SPP1 modulated vasoconstriction in response to 1 to 100 nmol/L exogenous S1P, a concentration range that was characterized as S1P2-dependent, based on the effect of S1P(2) inhibition by antisense oligonucleotides and 1 mumol/L JTE013. Inhibition of the cystic fibrosis transmembrane regulator (CFTR) (1) restored S1P responses that were attenuated by SPP1(wt) overexpression; (2) enhanced myogenic vasoconstriction; but (3) had no effect on noradrenaline responses. We conclude that SPP1 is an endogenous regulator of resistance artery tone that functionally antagonizes the vascular effects of both Sk1(wt) and S1P2 receptor activation. SPP1 accesses extracellular S1P pools in a manner dependent on a functional CFTR transport protein. Our study assigns important roles to both SPP1 and CFTR in the physiological regulation of vascular tone, which influences both tissue perfusion and systemic blood pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583713      PMCID: PMC2746908          DOI: 10.1161/CIRCRESAHA.108.173575

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

1.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Sphingosine-1-phosphate receptors and the development of the vascular system.

Authors:  Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2002-05-23

3.  Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate.

Authors:  L C Boujaoude; C Bradshaw-Wilder; C Mao; J Cohn; B Ogretmen; Y A Hannun; L M Obeid
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

4.  Characterization of murine sphingosine-1-phosphate phosphohydrolase.

Authors:  Hervé Le Stunff; Courtney Peterson; Rosemary Thornton; Sheldon Milstien; Suzanne M Mandala; Sarah Spiegel
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

5.  Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.

Authors:  Steffen-Sebastian Bolz; Lukas Vogel; Daniel Sollinger; Roland Derwand; Cor de Wit; Gervaise Loirand; Ulrich Pohl
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

Review 6.  Pleiotropic actions of sphingosine-1-phosphate.

Authors:  Kenneth Watterson; Heidi Sankala; Sheldon Milstien; Sarah Spiegel
Journal:  Prog Lipid Res       Date:  2003-07       Impact factor: 16.195

Review 7.  Sphingosine-1-phosphate: an enigmatic signalling lipid.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Mol Cell Biol       Date:  2003-05       Impact factor: 94.444

8.  Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.

Authors:  Douglas H Deutschman; Jeffrey S Carstens; Robert L Klepper; Wyatt S Smith; M Trevor Page; Thomas R Young; Lisa A Gleason; Nobuko Nakajima; Roger A Sabbadini
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

9.  Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival.

Authors:  J R Van Brocklyn; M J Lee; R Menzeleev; A Olivera; L Edsall; O Cuvillier; D M Thomas; P J Coopman; S Thangada; C H Liu; T Hla; S Spiegel
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

10.  Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.

Authors:  Hervé Le Stunff; Ismael Galve-Roperh; Courtney Peterson; Sheldon Milstien; Sarah Spiegel
Journal:  J Cell Biol       Date:  2002-09-16       Impact factor: 10.539

View more
  31 in total

1.  S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells.

Authors:  Kristen Park Hopson; Jessica Truelove; Jerold Chun; Yumei Wang; Christian Waeber
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

2.  A microfluidic platform for probing small artery structure and function.

Authors:  Axel Günther; Sanjesh Yasotharan; Andrei Vagaon; Conrad Lochovsky; Sascha Pinto; Jingli Yang; Calvin Lau; Julia Voigtlaender-Bolz; Steffen-Sebastian Bolz
Journal:  Lab Chip       Date:  2010-07-06       Impact factor: 6.799

Review 3.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

4.  CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.

Authors:  Christoph Tabeling; Hanpo Yu; Liming Wang; Hannes Ranke; Neil M Goldenberg; Diana Zabini; Elena Noe; Adrienn Krauszman; Birgitt Gutbier; Jun Yin; Michael Schaefer; Christoph Arenz; Andreas C Hocke; Norbert Suttorp; Richard L Proia; Martin Witzenrath; Wolfgang M Kuebler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-17       Impact factor: 11.205

Review 5.  S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.

Authors:  Anna Cantalupo; Annarita Di Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

Review 6.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

Review 7.  Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.

Authors:  Linda Sasset; Yi Zhang; Teresa M Dunn; Annarita Di Lorenzo
Journal:  Trends Endocrinol Metab       Date:  2016-08-22       Impact factor: 12.015

8.  Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

Authors:  Zhengrong Guan; Sean T Singletary; Anthony K Cook; Janet L Hobbs; Jennifer S Pollock; Edward W Inscho
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

9.  Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans.

Authors:  Wei-Ching Huang; Jie Liang; Masayuki Nagahashi; Dorit Avni; Akimitsu Yamada; Michael Maceyka; Aaron R Wolen; Tomasz Kordula; Sheldon Milstien; Kazuaki Takabe; Tamas Oravecz; Sarah Spiegel
Journal:  FASEB J       Date:  2016-04-29       Impact factor: 5.191

10.  Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.

Authors:  Maziar Divangahi; Haouaria Balghi; Gawiyou Danialou; Alain S Comtois; Alexandre Demoule; Sheila Ernest; Christina Haston; Renaud Robert; John W Hanrahan; Danuta Radzioch; Basil J Petrof
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.